What Albertsons Purchase of Rite Aid Means for Drug Retail
Albertsons is buying a big portion of Rite Aid to create a company worth $24 Billion. Shares of Rite Aid soared as much as 8 percent on the news. This acquisition comes as many retailers join forces to compete with Amazon, which is involved in nearly every industry from retail, to grocery, and now even healthcare. Wall Street Journal Reporter Heather Haddon and Bold Media's Business Editor David Grasso explain what this deal means for drug retail.
"Rite Aid was really put at a disadvantage right after the stuttered Walgreens deal," says Haddon. "This was really about Rite Aid helping to reposition themselves, get access to a whole new market of Albertsons customers, and in turn Albertsons gets a lot of pharmacy customers and cross-marketing opportunities."
"We are seeing a lot of disruption, and everyone is shaking in their boots," says Grasso. "It's all about survival.
Through this deal the integrated company will operate 4,900 locations, 4,350 pharmacy counters, and 320 clinics across 38 states and Washington, D.C.
The US Open kicks off in NYC, and USTA Chairman Dr. Brian Hainline discusses tennis’s growth, Djokovic's worries about pickleball, and the sport's future.
Hero Bread's viral low-carb, keto-friendly croissant, backed by celebrity investors like Tom Brady and Kevin Durant, is revolutionizing healthy eating.
Fed Chair Jerome Powell's Jackson Hole speech on Friday is expected to align with market expectations of upcoming rate cuts, likely beginning in September.
The former Microsoft CEO launched "Just the Facts" with USAFacts to provide clear, factual information on key issues, like health, the economy, and immigration.
